161.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised...
by Dormandy, John A
The Lancet (British edition), 2005, Vol.366 (9493), p.1279-1289
162.
Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management
by Paschou, Stavroula Α
The journal of clinical endocrinology and metabolism, 2017-10-01, Vol.102 (10), p.3621-3634
163.
Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo
by Williams, K. H
Endocrine reviews, 2013-02, Vol.34 (1), p.84-129
164.
Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort
by Anderson, Simon G
Diabetologia, 2017-12-21, Vol.61 (4), p.959-967
165.
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice
by Kim, M. Y
Diabetologia, 2012-10-23, Vol.56 (1), p.204-217
166.
Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study
by Tennant, Peter W. G
Diabetologia, 2013-11-29, Vol.57 (2), p.285-294
167.
The Association of Preoperative Glycemic Control, Intraoperative Insulin Sensitivity, and Outcomes after Cardiac Surgery
by Sato, Hiroaki
The journal of clinical endocrinology and metabolism, 2010-09, Vol.95 (9), p.4338-4344
168.
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
by Marso, Steven P., MD
The American heart journal, 2013, Vol.166 (5), p.823-830.e5
169.
Diabetes in Africa: epidemiology, management and healthcare challenges
by Levitt, N S
Heart (British Cardiac Society), 2008-11, Vol.94 (11), p.1376-23
170.
Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007–2011
by Assogba, Frank G. A
Diabetologia, 2014-02-06, Vol.57 (4), p.718-728
171.
Health and economic burden of the projected obesity trends in the USA and the UK
by Wang, Y Claire, MD
The Lancet (British edition), 2011, Vol.378 (9793), p.815-825
172.
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
by Jiang, Ying
European journal of epidemiology, 2011-01-01, Vol.26 (11), p.863-876
173.
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies
by Li, Donghui
Cancer causes & control, 2011-02-01, Vol.22 (2), p.189-197
174.
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203...
by Peters, Sanne A. E
Diabetologia, 2014-05-25, Vol.57 (8), p.1542-1551
175.
Diabetes Burden and Diabetes Distress: the Buffering Effect of Social Support
by Baek, Rachel N
Annals of behavioral medicine, 2014-02-19, Vol.48 (2), p.145-155
176.
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
by Home, P. D
Diabetologia, 2009-09-15, Vol.52 (12), p.2499-2506
177.
Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models
by Chen, Fang
Diabetologia, 2015-11-12, Vol.59 (2), p.316-324
178.
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk
by VESTERGAARD, P
Diabetologia, 2005, Vol.48 (7), p.1292-1299
179.
Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
by Yang, Rongrong
Diabetologia, 2019-06-05, Vol.62 (8), p.1403-1411
180.
Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline
by Copeland, Kenneth C
The journal of clinical endocrinology and metabolism, 2011-01, Vol.96 (1), p.159-167
